The prospective exploratory study of safety and efficacy on the patients post-penetrating keratoplasty of topical tacrolimus 0.1%.
Latest Information Update: 01 Nov 2022
At a glance
- Drugs Tacrolimus (Primary)
- Indications Transplant rejection
- Focus Therapeutic Use
- 28 Oct 2022 Status changed from active, no longer recruiting to completed.
- 26 Apr 2020 Status changed from not yet recruiting to active, no longer recruiting.
- 02 Nov 2017 New trial record